Electra Therapeutics adopts amended, restated bylaws effective at IPO close - ETRA News | RalliesElectra Therapeutics adopts amended, restated bylaws effective at IPO close
E
ETRA• Bylaws and certificate changes took effect at IPO close
- Electra Therapeutics adopted amended and restated bylaws effective Sept. 21, 2026 in connection with its IPO closing.
- Changes took effect alongside an amended and restated certificate of incorporation filed in Delaware on the same date.
- IPO closed Sept. 21, 2026 with 23,333,334 common shares sold at USD 15 per share, raising about USD 350 million gross.